DB24997InvestigationalVaccines
ChAd-triCoV/Mac is a biologic drug. ChAd-triCoV/Mac is under investigation in clinical trial NCT06381739 (A Trial of a Next Generation COVID-19 Vaccine Delivered by Inhaled Aerosol).
- Also known as
- ChAd-triCoV
- Code names
- ChAd-triCoV/Mac
What you can answer from here — as of February 06, 2026
Which companies are running trials of ChAd-triCoV/Mac, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account